Skip to main content


We examined the baseline characteristics of patients in the Ticlopidine Aspirin Stroke Study (TASS) to determine if the effects of the two treatments in preventing stroke differed in various subgroups. Patients with the following characteristics did less well on aspirin: elevated creatinine, hypertension or diabetes requiring treatment, or treatment with anticoagulant or antiplatelet drugs prior to their qualifying TIA or stroke. Women and patients with vertebrobasilar symptoms did particularly well on ticlopidine. We performed arteriography in 1,188 patients with carotid qualifying events. The frequency of stroke in patients with abnormal arteriograms ipsilateral to their symptoms was slightly higher than in those with normal carotid arteries. Ticlopidine was more effective in patients without carotid stenosis. Ticlopidine is more effective than aspirin in preventing strokes in patients having warning TIAs. The patients who benefit most from ticlopidine may be women, those who have vertebrobasilar symptoms, those with cerebral ischemic symptoms while on aspirin or anticoagulant therapy, and patients with diffuse atherosclerotic disease rather than high-grade carotid stenosis.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors


Published In

Volume 42Number 1January 1992
Pages: 111
PubMed: 1734290

Publication History

Published online: January 1, 1992
Published in print: January 1992


Request permissions for this article.


Affiliations & Disclosures

TASS Baseline and Angiographic Data Subgroup
From the Department of Neurology (Dr. Grotta), University of Texas Medical School, Houston, TX; Department of Neurology (Dr. Norris), University of Toronto, Toronto, ON, Canada; and Syntex Research (B. Kamm), Palo Alto, CA.
* Members of the Tass Baseline and Angiographic Data Subgroup: H.P. Adams, Iowa City, IA; B.A. Anderson, Winnipeg, MB, Canada; A. Bellavance, St. Lambert, PQ, Canada; J.A. Byer, Columbia, MO; J.R. Couch, Springfield, IL; B.H. Dobkin, Los Angeles, CA; M.J. Fisher, Los Angeles, CA; G.R. Hanna, Charlottesville, VA; L.A. Hershey, Cleveland, OH; C.S. Kase, Boston, MA; J.R. Lacy, Palo Alto, CA; L.L. Levy, West Haven, CT; C. Mayman, Boston, MA; J.S. Meyer, Houston, TX; C.P. Olinger, Cincinnati, OH; W. Pryse-Phillips, St. Johns, NF, Canada; J.T. Robertson, Memphis, TN; J.F. Rothrock, San Diego, CA; C.H. Sadowsky, Palm Beach, FL; P.D. Swanson, Seattle, WA; J. Taylor, Richmond, VA; and L.A. Weisberg, New Orleans, LA.

Metrics & Citations



Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Melatonin alleviates valproic acid-induced neural tube defects by modulating Src/PI3K/ERK signaling and oxidative stress, Acta Biochimica et Biophysica Sinica, (2023).
  2. NMDA Receptor Signaling Is Important for Neural Tube Formation and for Preventing Antiepileptic Drug-Induced Neural Tube Defects, The Journal of Neuroscience, 38, 20, (4762-4773), (2018).
  3. Lamotrigine Use in Pregnancy, Journal of Pharmacy Technology, 15, 3, (75-78), (2016).
  4. Stroke Management, Journal of Pharmacy Practice, 6, 6, (297-303), (2016).
  5. Pathophysiology, Medical Management, and Acute Rehabilitation of Stroke Survivors, Stroke Rehabilitation, (2-45), (2016).
  6. Effects of lacosamide “a novel antiepileptic drug” in the early stages of chicken embryo development, Child's Nervous System, 32, 9, (1715-1719), (2016).
  7. Foetal safety of old and new antiepileptic drugs, Expert Opinion on Drug Safety, 14, 10, (1563-1571), (2015).
  8. Experience with vertebral artery origin stenting and ostium dilatation: results of treatment and clinical outcomes, Journal of NeuroInterventional Surgery, 8, 5, (476-480), (2015).
  9. Recurrent Stroke while on Antiplatelet Therapy, Neurologic Clinics, 33, 2, (475-489), (2015).
  10. Managing epilepsy in pregnancy, Expert Review of Obstetrics & Gynecology, 6, 6, (667-680), (2014).
  11. See more

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text







Share article link